Back
State Street SPDR S&P Biotech ETF Vs. Carter's, Inc. Industry Stock Comparison
Buy
70
XBI
State Street SPDR S&P Biotech ETF
Last Price:
$129.00
Seasonality Move:
5.82%
Buy
55
CRI
Carter's, Inc.
Last Price:
$35.86
Seasonality Move:
1.9%
Buy
70
State Street SPDR S&P Biotech ETF (XBI)
is a Buy
Is State Street SPDR S&P Biotech ETF a Buy, Sell or Hold?
-
The current State Street SPDR S&P Biotech ETF [XBI] share price is $128.96. The Score for XBI is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
XBI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Carter's, Inc. (CRI)
is a Buy
Is Carter's, Inc. a Buy, Sell or Hold?
-
The current Carter's, Inc. [CRI] share price is $35.91. The Score for CRI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
CRI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XBI Stock Price Chart
What is State Street SPDR S&P Biotech ETF's stock price today?
-
The State Street SPDR S&P Biotech ETF share price today is $128.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XBI is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRI Stock Price Chart
What is Carter's, Inc.'s stock price today?
-
The Carter's, Inc. share price today is $35.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRI is experiencing buying pressure, which is a positive indicator for future bullish movement.
XBI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 58.53 | Buy |
| Chaikin Money Flow: | 5435802 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.15 - 126.99) | Buy |
| Bollinger Bands (100): | (118.76 - 127.36) | Buy |
CRI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 52.47 | Buy |
| Chaikin Money Flow: | 415895 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.1 - 35.4) | Buy |
| Bollinger Bands (100): | (31.49 - 37.79) | Buy |
XBI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.87 | Buy |
| 20-day SMA: | 123.7 | Buy |
| 50-day SMA: | 125.15 | Buy |
| 200-day SMA: | 108.61 | Buy |
| 8-day EMA: | 125.1 | Buy |
| 20-day EMA: | 124.22 | Buy |
| 50-day EMA: | 123.95 | Buy |
| 200-day EMA: | 112.43 | Buy |
CRI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.13 | Buy |
| 20-day SMA: | 34.69 | Buy |
| 50-day SMA: | 36.57 | Sell |
| 200-day SMA: | 31.99 | Buy |
| 8-day EMA: | 35.28 | Buy |
| 20-day EMA: | 35.36 | Buy |
| 50-day EMA: | 35.61 | Buy |
| 200-day EMA: | 35.4 | Buy |
State Street SPDR S&P Biotech ETF Earnings Growth & XBI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Carter's, Inc. Earnings Growth & CRI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.70 per share, a decrease this year of $0.22 per share, and an increase next year of $0.50 per share.
State Street SPDR S&P Biotech ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Carter's, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||